Said R. Beydoun MD
Neuromuscular Medicine, Neurophysiology, Pain Medicine
Professor of Neurology, USC School of Medicine
Join to view full profile
1520 San Pablo StSte 3000Los Angeles, CA 90033
Phone+1 323-442-5710
Fax+1 323-442-5736
Dr. Beydoun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Pain Medicine, 1985 - 1986- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurology, 1983 - 1984
University of Miami/Jackson Health SystemResidency, Neurology, 1981 - 1983
American University of Beirut Faculty of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1983 - 2028
FL State Medical License 1982 - 1998
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- American Board of Psychiatry and Neurology Pain Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2014-2017
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
- Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy Start of enrollment: 2008 Aug 22
- Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Publications & Presentations
PubMed
- C9ORF72-associated bulbar-onset ALS in a patient with secondary progressive multiple sclerosis and conjugal ALS.Kamran Moradi, Yaesshna Pillay, Christina J Azevedo, Leila Darki, Said R Beydoun
Neurological Sciences. 2026-09-26 - DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.Sabrina Paganoni, Lori B Chibnik, Melanie Quintana, Eric A Macklin, Michelle A Detry
JAMA Network Open. 2026-09-01 - 2 citationsEvaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study.Tuan Vu, Said R Beydoun, Richard J Nowak, Hans Katzberg, Maria Ait-Tihyaty
European Journal of Neurology. 2026-05-01
Journal Articles
- Late-Onset Hereditary Tranthyretin Amyloidosis in Two Patients with Acquired Demyelinating FeaturesNazila Rad, Said R Beydoun, US Neurology, 11/6/2018
- The Challenge of Distinguishing POEMS from Chronic Inflammatory Demyelinating Polyneuropathy-Importance of Early Recognition and Diagnosis of POEMSFrancis Chow, Leila Darki, Said R Beydoun, US Neurology, 11/6/2018
- Edaravone in Amyotrophic Lateral Sclerosis - Lessons from the Clinical Development Program and the Importance of a Clinical Trial DesignSaid R Beydoun, Jeffrey Rosenfeld, US Neurology, 2018
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
